| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.009 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |